Bayer brand A1CNow+ MULTI-TEST A1C SYSTEM TEST KITS (PART NUMBER 3021/08842610); Hemoglobin A1c Monitor; Glycosylated Hemoglobin Assay; Product is manufactured and distributed by Bayer HealthCare LLC, Sunnyvale, CA The A1CNow+ test provides quantitative measurement of the percent of glycated hemoglobin (%HbA1c or %A1C) levels in capillary (fingerstick) or venous whole blood samples. The test is for professional use to monitor glycemic control in people with diabetes.
Publicado el 13 de noviembre de 2013 · Inicio del retiro: 26 de agosto de 2013
Resumen
FDA registra el retiro Z-0136-2014 de dispositivos médicos de Clase II, publicado el 13 de noviembre de 2013 e iniciado el 26 de agosto de 2013. Empresa responsable: Bayer Healthcare Llc; Estado: Finalizado; Cantidad reportada: 138 Kits in US (Total 2452); Lote: Lot: 1300733 (US, China); Lot: 1300712 (Argentina, Uruguay); Lots: 1300711, 130012 (Japan). La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Test results from these lots may produce a high-bias reading (by up to 20%) that is outside of limits defined for stability and product accuracy when product is stored at room temperature four (4) to five (5) months after release.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Bayer Healthcare Llc
- Distribuidor
- Worldwide Distribution - USA (nationwide) and Internationally to China, Argentina, Uruguay, Japan.
- Lote
- Lot: 1300733 (US, China); Lot: 1300712 (Argentina, Uruguay); Lots: 1300711, 130012 (Japan)
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAEdwards Lifesciences Dispersion Aortic Perfusion Cannula with Duraflo Coating, Sterile, RX only For Single Use13 de noviembre de 2013
- FDASurgicutt fully automated incision making device for bleeding time determination. ITC 8 Olsen Avenue, Edison,13 de noviembre de 2013
- FDAEdwards Lifesciences Fem-Flex Femoral Arterial Cannula with Duraflo Coating, DIITFA02225, Sterile, RX only For13 de noviembre de 2013
- FDAStereotactic Circular Collimator - 3D Line stereotatic Hardware Accessories The device is part of the class of13 de noviembre de 2013
- FDAThe EkoSonic Endovascular System employs high frequency (2-2.5 MHz), low power (0.585 watt average power per13 de noviembre de 2013
- FDAPatient Cart used in conjunction with the da Vinci S surgical and SI System. Intuitive Surgical 1266 Kifer13 de noviembre de 2013
Preguntas sobre este retiro
¿Bayer brand A1CNow+ MULTI-TEST A1C SYSTEM TEST KITS (PART NUMBER 3021/08842610); Hemoglobin A1c Monitor; Glycosylated Hemoglobin Assay; Product is manufactured and distributed by Bayer HealthCare LLC, Sunnyvale, CA The A1CNow+ test provides quantitative measurement of the percent of glycated hemoglobin (%HbA1c or %A1C) levels in capillary (fingerstick) or venous whole blood samples. The test is for professional use to monitor glycemic control in people with diabetes. fue retirado del mercado?
Sí. FDA publicó el retiro Z-0136-2014 el 13 de noviembre de 2013. Peligro reportado: Test results from these lots may produce a high-bias reading (by up to 20%) that is outside of limits defined for stability and product accuracy when product is stored at room temperature four (4) to five (5) months after release.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter